The increasing prevalence of hospital and community-acquired infections caused by
multidrug-resistant (MDR) bacterial pathogens is limiting the options for effective antibiotic …

In the present scenario, resistance to antibiotics is one of the crucial issues related to public
health. Earlier, such resistance to antibiotics was limited to nosocomial infections, but it has …

In the face of increasing antimicrobial resistance and the paucity of new antimicrobial agents
it has become clear that new antimicrobial strategies are urgently needed. One of these is to …

The fight against multidrug-resistant (MDR) pathogens continues. This article discusses the
gap between the need for new antibiotics and lean research and development (R&D) …

The emerging problem of antibiotic resistance is a serious threat to global public health. The
situation is aggravated by a substantial decline in the research and development of …

The evolving problem of antimicrobial resistance in Pseudomonas aeruginosa,
Acinetobacter baumannii and Klebsiella pneumoniae has led to the emergence of clinical …

The spread of multidrug-resistant bacteria is an ever-growing concern, particularly among
Gram-negative bacteria because of their intrinsic resistance and how quickly they acquire …

This article gives a very brief overview of the antibiotic era, beginning from the discovery of
first antibiotics until the present day situation, which is marred by the emergence of hard-to …

The pandemic of multidrug-resistant (MDR) pathogens and their continuing spread is
beyond dispute. In contrast to the past, today's antibacterial research and development …

Despite the constantly increasing need for new antimicrobial agents, antibiotic drug
discovery and development seem to have greatly decelerated in recent years. Presented …